EFFECT OF FOOD ON THE PHARMACOKINETICS OF ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITOR CERITINIB IN HEALTHY SUBJECTS.

被引：0
|
作者：
Lau, Y. [1 ]
Lin, T. [1 ]
Song, D. [1 ]
Gu, J. [1 ]
Yu, R. [1 ]
Joe, A. [1 ]
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2015年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-043
引用
收藏
页码：S71 / S72
页数：2
相关论文
共 50 条
  • [31] Anaplastic lymphoma kinase (ALK) in rhabdomyosarcoma.
    van Gaal, J. C.
    Flucke, U. E.
    Roeffen, M. H. S.
    de Bont, E. S.
    Suurmeijer, A. J.
    van der Graaf, W. T.
    Versleijen-Jonkers, Y. M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] Implications of ALK (anaplastic lymphoma kinase) in oncohematology
    Cluzeau, T.
    Pecuchet, N.
    Mounier, N.
    Vignot, S.
    BULLETIN DU CANCER, 2010, 97 (08) : 991 - 996
  • [33] Translocations involving anaplastic lymphoma kinase (ALK)
    Duyster, J
    Bai, RY
    Morris, SW
    ONCOGENE, 2001, 20 (40) : 5623 - 5637
  • [34] Anaplastic Lymphoma Kinase (ALK) Positive Neuroendocrine Tumor of Lung With Favorable Response to Alectinib (ALK Inhibitor)
    Ghimire, Bipin
    Pokharel, Ashbita
    Karki, Ujjwal
    Thapa, Shrinjaya
    Chisti, Mohammad Muhsin
    CLINICAL LUNG CANCER, 2023, 24 (03) : e113 - e116
  • [35] Translocations involving anaplastic lymphoma kinase (ALK)
    Justus Duyster
    Ren-Yuan Bai
    Stephan W Morris
    Oncogene, 2001, 20 : 5623 - 5637
  • [36] Lack of an effect of ezetimibe on the pharmacokinetics of torcetrapib/atorvastatin in healthy subjects.
    Diringer, K.
    Gibbs, M. A.
    Amin, N.
    LaBadie, R.
    Thuren, T. T.
    Shear, C. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S110 - S111
  • [37] EFFECT OF MULTIPLE DOSES OF ISAVUCONAZOLE ON THE PHARMACOKINETICS OF METFORMIN IN HEALTHY SUBJECTS.
    Desai, A.
    Yamazaki, T.
    Kowalski, D.
    Lademacher, C.
    Pearlman, H.
    Rammelsberg, D.
    Townsend, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S41 - S41
  • [38] Lack of effect of ketoconazole on the pharmacokinetics of oral bexarotene in healthy subjects.
    Kuan, H
    Loewen, G
    Geiser, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P74 - P74
  • [39] The effect of dosing regimen on the pharmacokinetics of risedronate administered to healthy subjects.
    Mitchell, DY
    Eusebio, RA
    Heise, MA
    Pallone, KA
    Clay, ME
    Russell, DA
    Melson, CW
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M661 - M661
  • [40] Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population
    Fischer, M.
    Wulff, B.
    Baruchel, S.
    Berlanga, P.
    Trahair, T.
    Mechinaud, F.
    Schulte, J.
    Modak, S.
    Merks, J. H.
    Zwaan, C. M.
    Marshall, L. V.
    Casanova, M.
    Branle, F.
    Malet, I.
    Emeremni, A. C.
    Geoerger, B.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S49 - S50
12345